Nafamostat is hydrolysed by human liver cytosolic long-chain acyl-CoA hydrolase-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nafamostat is hydrolysed by human liver cytosolic long-chain acyl-CoA hydrolase

Published:2007-03 Issue:3 Volume:37 Page:260-270
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Yamaori S.,Ukena E.,Fujiyama N.,Funahashi T.,Kimura T.,Yamamoto I.,Ohshima T.,Matsumura K.,Oda M.,Watanabe K.

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/00498250601167091

Reference31 articles.

1. Synthesis and structure-activity study of protease inhibitors. IV. Amidinonaphthols and related acyl derivatives.

2. Intracellular localization of palmitoyl-CoA hydrolase and palmitoyl-CoA synthetase in human blood platelets and liver

3. Purification, Properties, and Specificity of Rat Brain Cytosolic Fatty Acyl Coenzyme A Hydrolase

4. The Hydrolysis of Long-chain Fatty Acid Esters of Cholesterol with Rat Liver Enzymes

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. Viruses 2022, 14, 177;Viruses;2022-07-13

2. Use of nafamostat mesilate for anticoagulation during extracorporeal membrane oxygenation: A systematic review;Artificial Organs;2022-05-09

3. Incidence and risk factors for hyperkalaemia in patients treated for COVID‐19 with nafamostat mesylate;Journal of Clinical Pharmacy and Therapeutics;2022-03-21

4. Predicting the systemic exposure and lung concentration of nafamostat using physiologically-based pharmacokinetic modeling;Translational and Clinical Pharmacology;2022

5. Co-Spray Dried Nafamostat Mesylate with Lecithin and Mannitol as Respirable Microparticles for Targeted Pulmonary Delivery: Pharmacokinetics and Lung Distribution in Rats;Pharmaceutics;2021-09-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3